FLEXCATH ADVANCE STEERABLE SHEATH
Report
- Report Number
- 3002648230-2024-00279
- Event Type
- Injury
- Date Received
- June 26, 2024
- Date of Event
- May 12, 2024
- Report Date
- June 26, 2024
- Manufacturer
- MEDTRONIC CRYOCATH LP
- Product Code
- DRA
- PMA / PMN Number
- K123591
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PO
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
THIS INFORMATION IS BASED ENTIRELY ON JOURNAL LITERATURE. MEDTRONIC WAS MADE AWARE OF THIS EVENT THROUGH A SEARCH OF LITERATURE PUBLICATIONS. THIS EVENT OCCURRED OUTSIDE THE US. PATIENT INFORMATION IS LIMITED DUE TO CONFIDENTIALITY CONCERNS. OF NOTE, MULTIPLE PATIENTS AND MULTIPLE MANUFACTURERS WERE NOTED IN THE ARTICLE; HOWEVER, A ONE-TO-ONE CORRELATION COULD NOT BE MADE WITH UNIQUE PRODUCT SERIAL/LOT NUMBERS. THE BASELINE GENDER/AGE CHARACTERISTICS IS MALE/59 YEARS OLD. WITHOUT A LOT NUMBER OR DEVICE SERIAL NUMBER, THE MANUFACTURING DATE CANNOT BE DETERMINED. SINCE NO DEVICE ID WAS PROVIDED, IT IS UNKNOWN IF THIS EVENT HAS BEEN PREVIOUSLY REPORTED. A REQUEST FOR ADDITIONAL INFORMATION WAS MADE. IF ADDITIONAL INFORMATION IS OBTAINED REGARDING THIS EVENT, IT WILL BE ADDED, AND A SUPPLEMENTAL REPORT WILL BE SUBMITTED ACCORDINGLY. REFERENCED ARTICLE: SEX-BASED DIFFERENCES AND RISK OF RECURRENCE IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PULMONARY VEIN ISOLATION. INTERNATIONAL JOURNAL OF CARDIOLOGY. 2024. 409; 132161. DOI: 10.1016/J.IJCARD.2024.132161 MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.
LITERATURE WAS REVIEWED REGARDING SEX DIFFERENCES IN PATIENTS UNDERGOING CATHETER ABLATION. THE AUTHORS DESCRIBED PATIENTS WHO UNDERWENT CRYOABLATION AND EXPERIENCED SEVERE ACCESS SITE BLEEDING, PHRENIC NERVE INJURY, GAS EMBOLISM, HIGH-GRADE ATRIOVENTRICULAR BLOCK, UPPER AIRWAY BLEEDING, HEMATOMA, VENOUS THROMBOSIS, ARTERIOVENOUS FISTULA, FEMORAL PSEUDOANEURYSM, PERICARDITIS, CARDIAC TAMPONADE, AND PERICARDIAL EFFUSION. ONE PATIENT PRESENTED WITH A PERICARDIAL EFFUSION AT THE END OF THE PROCEDURE FOR WHICH THEY UNDERWENT PERICARDIOCENTESIS; AND LATER DEVELOPED PERICARDITIS. ANOTHER PATIENT SUFFERED A GAS EMBOLISM DURING THE PROCEDURE WITH CONCOMITANT ST SEGMENT ELEVATION, WHICH LED TO PROMPT CORONARY ANGIOGRAPHY; AFTER THE PROCEDURE, THIS PATIENT ALSO SUFFERED CARDIAC TAMPONADE REQUIRING PERICARDIOCENTESIS AND LATER DEVELOPED PERICARDITIS AFTER THE TAMPONADE WAS RESOLVED. THE STATUS OF THE CATHETERS AND SHEATHS IS UNKNOWN. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2102196 | FLEXCATH ADVANCE STEERABLE SHEATH | CATHETER, STEERABLE | DRA | MEDTRONIC CRYOCATH LP | 4FC12 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 59 YR | Male | Life Threatening| R |